Vaxart's oral norovirus vaccine shows promise in mid-stage trials, reducing infections by 30%. Read more here.

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

An oral vaccine reduced infection risk in a trial where people were deliberately exposed to high doses of norovirus, and ...

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is ...

While anti-amyloid monoclonal antibodies open exciting possibilities ... All three are available in pill form; rivastigmine also has a patch formulation, often used for people who cannot take ...

Regular use of a common pain reliever weakens key immune system functions, potentially increasing infection risk and slowing ...

Presidents have undergone annual physical exams and selectively released results to the public for years, but there are no ...

While anti-amyloid monoclonal antibodies open exciting possibilities in disease modification ... All three are available in pill form; rivastigmine also has a patch formulation, often used for people ...

The global antibody and protein labeling kits market is projected to grow significantly over the next decade, increasing from approximately USD 685 million in 2024 to over USD 1.56 billion by 2034, ...

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some ...

Of the 157 000 children living with HIV in South Africa, around one in three are not getting the medicines they need to stay ...

Mike McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, delivered an upbeat message at the ASGCT annual conference in New Orleans last week, showcasing the progress being made ...